التفاصيل البيبلوغرافية
| العنوان: |
Evaluation in vitro and in animals of a new C-labeled PET radioligand for metabotropic glutamate receptors 1 in brain. |
| المؤلفون: |
Zanotti-Fregonara, Paolo, Barth, Vanessa, Liow, Jeih-San, Zoghbi, Sami, Clark, David, Rhoads, Emily, Siuda, Edward, Heinz, Beverly, Nisenbaum, Eric, Dressman, Bruce, Joshi, Elizabeth, Luffer-Atlas, Debra, Fisher, Matthew, Masters, John, Goebl, Nancy, Kuklish, Steven, Morse, Cheryl, Tauscher, Johannes, Pike, Victor, Innis, Robert |
| المصدر: |
European Journal of Nuclear Medicine & Molecular Imaging; Feb2013, Vol. 40 Issue 2, p245-253, 9p, 1 Color Photograph, 1 Diagram, 3 Charts, 5 Graphs |
| مصطلحات موضوعية: |
IN vitro studies, GLUTAMATE receptors, POSITRON emission tomography, BRAIN tomography, RADIOLIGAND assay, ANIMAL models in research |
| مستخلص: |
Purpose: Two allosteric modulators of the group I metabotropic glutamate receptors (mGluR1 and mGluR5) were evaluated as positron emission tomography (PET) radioligands for mGluR1. Methods: LY2428703, a full mGluR1 antagonist (IC 8.9 nM) and partial mGluR5 antagonist (IC 118 nM), and LSN2606428, a full mGluR1 and mGluR5 antagonist (IC 35.3 nM and 10.2 nM, respectively) were successfully labeled with C and evaluated as radioligands for mGluR1. The pharmacology of LY2428703 was comprehensively assessed in vitro and in vivo, and its biodistribution was investigated by liquid chromatography-mass spectrometry/mass spectrometry, and by PET imaging in the rat. In contrast, LSN2606428 was only evaluated in vitro; further evaluation was stopped due to its unfavorable pharmacological properties and binding affinity. Results: C-LY2428703 showed promising characteristics, including: (1) high potency for binding to human mGluR1 (IC 8.9 nM) with no significant affinity for other human mGlu receptors (mGluR2 through mGluR8); (2) binding to brain displaceable by administration of an mGluR1 antagonist; (3) only one major radiometabolite in both plasma and brain, with a negligible brain concentration (with 3.5 % of the total radioactivity in cerebellum) and no receptor affinity; (4) a large specific and displaceable signal in the mGluR1-rich cerebellum with no significant in vivo affinity for mGluR5, as shown by PET studies in rats; and (5) lack of substrate behavior for efflux transporters at the blood-brain barrier, as shown by PET studies conducted in wild-type and knockout mice. Conclusion: C-LY2428703, a new PET radioligand for mGluR1 quantification, displayed promising characteristics both in vitro and in vivo in rodents. [ABSTRACT FROM AUTHOR] |
|
Copyright of European Journal of Nuclear Medicine & Molecular Imaging is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Find this article in full text from Springer Verlag. 
Full Text Finder